| Monday June 10 |
||
| 08.00 | Acute stroke & carotid management | |
| Chairmen: K. Mathias, R. McWillams, F. Speziale, L. N. Hopkins | ||
| 08.00 | Case reports and recorded video cases  |
|
| Complex stroke intervention, L.N. Hopkins |
||
| Multifocal arteriopathy with stroke, B. Faurie | ||
| 08.20 |
Which stroke can benefit from Lysis and Thrombectomy? L. N. Hopkins | |
| 08.27 | Which stroke must be treated by CAS and what are the advantages over surgery? P. Schneider | |
| 08.34 | The Python catheter: is it useful for acute stroke? G. Coppi | |
| 08.41 | Carotid surgery for acute stroke, F. Speziale | |
| 08.48 | Carotid dissection needs stents, S. Ronchey | |
| 08.55 | No way, carotid dissection needs conservative treatment, P. Cao | |
| 09.02 | How to organize the workflow within and outside the hospital? Logistic of stroke management, K. Mathias |
|
| 09.09 | Discussion | |
| 09:20 | Case reports and recorded video cases |
|
| Left internal carotid artery stenting with OCT evaluation, M. Amor |
||
| From functional imaging to stroke cure, K. Mathias | ||
| 09.45 | Coffee break | |
| 10.15 |
Carotid angioplasty for asymptomatic patients |
|
| Chairmen: Z. Krajcer, D. Raithel, M. Wholey, C. Setacci | ||
| 10.15 |
Case reports and recorded video cases |
|
| CAS with proximal protection: Mo.Ma. System, P. Montorsi | ||
| CAS for controlateral occlusion, P. Schneider | ||
| CAS in post-CEA restenosis and intimal flap asymptomatic patient, C. Setacci | ||
| 10.50 | CAS technology advancements: access, stents, CPD, Learning curve, P. Cao | |
| 10.57 | Which carotid procedures are required to grade the stroke risk? C. Setacci | |
| 11.04 | MI and TIA are equivalent for CAS outcome in asymptomatic patients, B. Faurie | |
| 11.11 | When to refute CAS for asymptomatic patients? C. Rabbia | |
| 11.18 | Is flow reversal the best protective device, S. Ronchey | |
| 11.25 | How the large ACST-2 Trial can help the future debate on CEA vs CAS, A. Halliday | |
| 11.32 | Indication of CAS and on recent trial results, M. Wholey | |
| 11.39 | Discussion | |
| 11.50 | Case reports and recorded video cases |
|
| Cervical reverse flow (michi procedure), I Van Herzeele | ||
| Carotid artery stenting: the tale of five stents, Z. Krajcer | ||
| Discussion | ||
| 12.30 | Lunch break on the exhibition hall |
|
| 12.30 | South Africa luncheon session |  luncheon symposium |
|||
| 12.30 | Endovascular management of HIV vasculopathy, A. Ramnarine |
Catheter-based renal sympathetic denervation with New Vessix System | |||
| 12.45 | Patient related radiation risks in endovascular procedures, J. Pillai | ||||
| 13.00 | Concerns in the endovascular management of traumatic thoracic transections, I. Casimjee | ||||
| 13.15 | Expanding the role of endovascular, R. Goga | ||||
| 13.30 | The concept: endovascular sac filling during TEVAR and EVAR, J. Pillai | ||||
| 13.45 | Discussion |
| 14.00 | Aortic branch malperfusion Chairmen: P. Cao, C. Nienaber, R. Chiesa  |
|
| 14.00 | International Society of Endovascular Specialists (ISES): Historical note related to European contribution, J. Busquet |
|
| 14.05 | Case reports and recorded video cases |
|
| Stent graft for chronic type B dissection, N. Mangialardi | ||
| Renal artery occlusive disease and infrarenal aortic occlusion, R. McWilliams | ||
| 14.25 | New IRAD datas, S. Trimarchi | |
| 14.32 | Diagnosis and treatment of Type B dissection with malperfusion, G. Melissano | |
| 14.39 | Update on «Off-the-shelf devices», M. Farber | |
| 14.46 | Chimps for acute type B dissection, M. Lachat | |
| 14.53 | Which place for emergent intervention in complicated acute type B dissection, N. Mangialardi | |
| 15.00 | Which place for emergent intervention in acute non complicated type B dissection, J. Brunkwall | |
| 15.07 | Salvage of a visceral artery raising from the false channel, A. Ruffino | |
| 15.14 | Role of branched and fenestrated stent grafts in TAD, P. Kasprzak | |
| 15.21 | TEVAR for type B TAD: when and how? E. Verhoeven | |
| 15.28 | When can we neglect a renal malperfusion and when is it an emergency? T. Sos | |
| 15.35 | Discussion | |
| 15.50 | Case reports and recorded video cases |
|
| Endocutting of the dissection membrane after acute type A dissection with aortic branch malperfusion, T. Larzon | ||
| Two cases of endovascular treatment of aortic arch, C. Ferrer | ||
| 16.10 | Coffee break | |
| 16.40 | Lower extremity challenges and some ideas on how to solve them | |
| Chairmen: M. Amor, G. Tepe, C. Liapis, C. Ruotolo | ||
| 16.40 | Case reports and recorded video cases |
|
| Endovascular management of a complex aortoiliac occlusion utilizing an IVUS re-entry device, A. Amin | ||
| Iliac case treated with covered stent, C. Rabbia | ||
| 17.00 | The last challenging frontier for DEB: highly calcified and long lesion in SFA. What do we know at the moment? A Micari |
|
| 17.07 | When and how to use CTO devices in the femoral-popliteal segment, Y. Gouëffic | |
| 17.14 | New dual component designs for SFA, M. Amor | |
| 17.21 | Debate. Our future treatment of SFA and popliteal arteries will be mostly: | |
| - Drug coated balloons, C. Rabbia | ||
| - Drug eluting stents, G. Tepe | ||
| - Atherectomy, M. Fusaro | ||
| 17.42 | What is the optimal treatment for in-stent restenosis? C. Liapis | |
| 17.49 | Is there still a place for distal bypass? A. Stella | |
| 17.56 | Endovascular repair of combined occluded femoral and popliteal arteries, A. Amin | |
| 18.03 | Discussion | |
| 18.15 | Case reports and recorded video cases |
|
| Multilevel angioplasty for CLI quadruple angioplasty external Iliac, lower popliteal, peroneal trunk, anterior tibial arteries, M. Amor | ||
| PAA case with covered stent, E. Ducasse | ||
| Discussion | ||
| 19.00 | End of the sessions |
